Rubicon Research Pre-IPO - Robust Product Development Pipeline Driving Revenue Growth
Rubicon Research Limited is looking to raise about US$130m in its India IPO. In this note, we talk about the company’s historical performance.
446 Views
US segment drags overall performance
STR reported a lower than expected performance in 2QFY22 due to continued headwinds in the US business. Sales in other regulated markets witnessed...
349 Views
Strides Pharma Science: Unanticipated De-Growth Across Markets..
Strides reported a weak quarter witnessing a de-growth across revenues of 12% YoY to Rs.688cr during Q1FY22 owing to major sector headwinds such as...
191 Views
US/Institutional business drives earnings
STR's 4QFY21 operational performance was marginally below our estimate. The robust performance in the US/Institutional segment within emerging...
292 Views
India Small Caps: Position for Outperformance Vs Large & Mid Caps
Late Friday evening, the Securities and Exchange Board of IndianÂ
694 Views